<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE collection SYSTEM "BioC.dtd">
<collection><source>GO_Annotation</source><date>20130316</date><key>go_annotation.key</key><document><id>21177871</id><passage><infon key="type">paragraph</infon><offset>18381</offset><annotation id="21177871_1"><infon key="gene">Akap7(361458)</infon><infon key="go-term">protein kinase A regulatory subunit binding|GO:0034237</infon><infon key="goevidence">IDA</infon><infon key="type">GOA</infon><location offset="18381" length="291"/><location offset="18676" length="105"/><text>In order to identify small molecules disrupting AKAP-PKA interactions, we developed an ELISA-based screening assay, where full-length AKAP18delta was added to RIIalpha subunits of PKA bound to 384-well microtiter plates. Interaction was detected using primary antibodies specific for AKAP18d , secondary peroxidase-conjugated antibodies, and a chemiluminescent peroxidase substrate (Fig. 1A) (12).</text></annotation><annotation id="21177871_2"><infon key="gene">Akap7(361458)</infon><infon key="go-term">protein kinase A regulatory subunit binding|GO:0034237</infon><infon key="goevidence">IDA</infon><infon key="type">GOA</infon><location offset="18925" length="211"/><text>This peptide inhibited the AKAP18delta-RIIalpha subunit interaction with an IC50 value of 10 nm, whereas the inactive control peptide AKAP18delta-PP did not affect the interaction in concentrations of up to 1 mm</text></annotation></passage><passage><infon key="type">fig_caption</infon><offset>19579</offset><annotation id="21177871_3"><infon key="gene">Prkar2a(29699)</infon><infon key="go-term">protein kinase A regulatory subunit binding|GO:0034237</infon><infon key="goevidence">IDA</infon><infon key="type">GOA</infon><location offset="19579" length="111"/><text>FMP-API-1 inhibits the interaction between AKAP18delta and RIIalpha by allosteric binding to the RII subunits. </text></annotation><annotation id="21177871_4"><infon key="gene">Prkar2a(29699)</infon><infon key="go-term">protein binding|GO:0005515</infon><infon key="goevidence">IPI</infon><infon key="type">GOA</infon><location offset="19579" length="111"/><text>FMP-API-1 inhibits the interaction between AKAP18delta and RIIalpha by allosteric binding to the RII subunits. </text></annotation><annotation id="21177871_5"><infon key="gene">Prkar2a(29699)</infon><infon key="go-term">small molecule binding|GO:0036094</infon><infon key="goevidence">IDA</infon><infon key="type">GOA</infon><location offset="21483" length="100"/><text>E, the peptide Ht31 and the small molecules FMP-API-1 and FMP-API-1/27 bind additively to RIIalpha. </text></annotation><annotation id="21177871_6"><infon key="gene">Prkar2a(29699)</infon><infon key="go-term">small molecule binding|GO:0036094</infon><infon key="goevidence">IDA</infon><infon key="type">GOA</infon><location offset="21834" length="48"/><text>F, FMP-API-1 binds to full-length PKA RIIalpha. </text></annotation></passage><passage><infon key="type">paragraph</infon><offset>27450</offset><annotation id="21177871_7"><infon key="gene">Prkar2a(29699)</infon><infon key="go-term">small molecule binding|GO:0036094</infon><infon key="goevidence">IDA</infon><infon key="type">GOA</infon><location offset="27994" length="97"/><text>Binding of FMP-API-1 to the full-length RIIalpha subunit is noncovalent and reversible (Fig. 1F).</text></annotation><annotation id="21177871_8"><infon key="gene">Prkar2a(29699)</infon><infon key="go-term">small molecule binding|GO:0036094</infon><infon key="goevidence">IDA</infon><infon key="type">GOA</infon><location offset="28298" length="209"/><text>Additional support for non-covalent binding of FMP-API-1 to RIIalpha subunits stems from mass spectrometric analyses of recombinant RIIalpha subunits after incubation with the compound (2 h, room temperature).</text></annotation></passage><passage><infon key="type">paragraph</infon><offset>42353</offset><annotation id="21177871_9"><infon key="gene">Adrb1(24925)</infon><infon key="go-term">positive regulation of calcium ion transport|GO:0051928</infon><infon key="goevidence">IDA</infon><infon key="type">GOA</infon><location offset="42802" length="160"/><text>These show that FMP-API-1 (100 mum), applied through the patch pipette, abolished Ca2+ current increases stimulated by the beta-adrenergic agonist ISO (100 nm).</text></annotation></passage></document></collection>
